Image-Guided Total-Marrow Irradiation Using Helical Tomotherapy in Patients With Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 273-279

  Wong, Jeffrey Y C ^a   Rosenthal, Joseph ^a   Liu, An ^a   Schultheiss, Timothy ^a   Forman, Stephen ^a   Somlo, George ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Helical tomotherapy; IMRT; Leukemia; Multiple myeloma

Indexed keywords

BONE; DIELECTRIC DEVICES; IRRADIATION; STANDARDS;

BONE MARROW TRANSPLANTATION; HELICAL TOMOTHERAPY; IMRT; LEUKEMIA; MULTIPLE MYELOMA;

TOXICITY;

DEXAMETHASONE; FLUDARABINE; MELPHALAN; RAPAMYCIN; TACROLIMUS; THALIDOMIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANOREXIA; APHERESIS; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIARRHEA; DRUG MEGADOSE; ERYTHEMA; ESOPHAGITIS; FATIGUE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPH NODE IRRADIATION; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NAUSEA; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL MOBILIZATION; TOMOTHERAPY; VOMITING; WHOLE BODY RADIATION;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; THERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 57649093632     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.071     Document Type: Article

References (22)

1. Blaise D., Maraninchi D., Michallet M., et al. Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission. Blood 97 (2001) 3669-3671
2. Dusenbery K.E., Daniels K.A., McClure J.S., et al. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys 31 (1995) 119-128
3. Ringden O., Ruutu T., Remberger M., et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 83 (1994) 2723-2730
4. Bunin N., Aplenc R., Kamani N., et al. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 32 (2003) 543-548
5. Clift R.A., Buckner C.D., Appelbaum F.R., et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 77 (1991) 1660-1665
6. Clift R.A., Buckner C.D., Appelbaum F.R., et al. Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood 92 (1998) 1455-1456
7. Wong J.Y.C., Liu A., Schultheiss T., et al. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation. Biol Blood Marrow Transplant 12 (2006) 306-315
8. Schultheiss T.E., Wong J., Liu A., et al. Image-guided total marrow and total lymphatic irradiation using helical tomotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1259-1267
9. Schultheiss T., Liu A., Wong J., et al. Total marrow and total lymphatic irradiation with helical tomotherapy. [Abstract]. Med Phys 31 (2004) 1845
10. Durie B.G.M., and Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36 (1975) 842-854
11. Pagel J.M., Matthews D.C., Appelbaum F.R., et al. The use of radioimmunoconjugates in stem cell transplantation. Bone Marrow Transplant 29 (2002) 807-816
12. 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: Results of two phase 1/2 trials. Blood 102 (2003) 2684-2691
13. Wong J.Y.C. Systemic targeted radionuclide therapy: Potential new areas. Int J Radiat Oncol Biol Phys 66 Suppl. (2006) S74-S82
14. Mackie T.R., Balog J., Ruchala K., et al. Tomotherapy. Semin Radiat Oncol 9 (1999) 108-117
15. Zaucha R.E., Buckner D.C., Barnett T., et al. Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies. Int J Radiat Oncol Biol Phys 64 (2006) 227-234
16. Bearman S., Appelbaum F.R., Buckner C.D., et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6 (1988) 1562-1568
17. Petropoulos D., Worth L.L., Mullen C.A., et al. Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies. Bone Marrow Transplant 37 (2006) 463-467
18. Weiner R., Bortin M., Gale R.P., et al. Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 104 (1986) 168-175
19. Travis E.L., Peters L.J., McNeil J., et al. Effect of dose-rate on total body irradiation: Lethality and pathologic findings. Radiother Oncol 4 (1985) 341-351
20. Sampath S., Schultheiss T.E., and Wong J. Dose response and factors related to interstitial pneumonitis following bone marrow transplant. Int J Radiat Oncol Biol Physics 63 (2005) 876-884
21. Tarbell N.J., Amato D.A., Down J.D., et al. Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 13 (1987) 1065-1069
22. 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: Final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 99 (2002) 731-735